Summit Therapeutics (SMMT) Return on Invested Capital (2020 - 2021)
Summit Therapeutics (SMMT) reported Return on Invested Capital of 0.01% for Q3 2021, little changed on a YoY basis from 0.01% in Q3 2020, and up 13.97% quarter-over-quarter from 0.01% in Q2 2021.
Summit Therapeutics (SMMT) Return on Invested Capital (2020 - 2021) Analysis & Trends
Summit Therapeutics has reported Return on Invested Capital for 2 years, with the latest figure at 0.01% in Q3 2021.
- For the quarter ending Q3 2021, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Sep 2021 stood at 0.01% (changed 0.0% YoY), and the FY2020 full-year result was 0.01%, up 7.0% from the prior year.
- Return on Invested Capital for Q3 2021 stood at 0.01%, up from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q2 2020, with the low at 0.01% in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.01% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -0.01% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Summit Therapeutics | 10.09 Bn | 9.99 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.01% |